These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 17393393)

  • 1. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
    Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
    Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
    Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
    J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.
    Targoff IN; Trieu EP; Plotz PH; Miller FW
    Arthritis Rheum; 1992 Jul; 35(7):821-30. PubMed ID: 1622421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease.
    Aiko N; Yamakawa H; Iwasawa T; Takemura T; Okudela K; Kitamura H; Hagiwara E; Ikeda S; Baba T; Iso S; Yamaguchi Y; Kondo Y; Kurabayashi T; Ohashi K; Sato S; Ogura T
    Respir Investig; 2020 May; 58(3):196-203. PubMed ID: 32094078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
    Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
    Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
    Sato S; Kuwana M; Hirakata M
    Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
    Targoff IN; Trieu EP; Miller FW
    J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis.
    Friedman AW; Targoff IN; Arnett FC
    Semin Arthritis Rheum; 1996 Aug; 26(1):459-67. PubMed ID: 8870113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y; Fujimoto M; Matsushita T; Kaji K; Komura K; Hasegawa M; Kodera M; Muroi E; Fujikawa K; Seishima M; Yamada H; Yamada R; Sato S; Takehara K; Kuwana M
    PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
    Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M
    Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome.
    Schneider F; Aggarwal R; Bi D; Gibson K; Oddis C; Yousem SA
    Arch Pathol Lab Med; 2015 Jan; 139(1):122-5. PubMed ID: 25549148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients.
    Horiki T; Ichikawa Y; Moriuchi J; Hoshina Y; Yamada C; Wakabayashi T; Jackson K; Inoko H
    Tissue Antigens; 2002 Jan; 59(1):25-30. PubMed ID: 11972875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.
    Chinoy H; Salway F; Fertig N; Shephard N; Tait BD; Thomson W; Isenberg DA; Oddis CV; Silman AJ; Ollier WE; Cooper RG;
    Arthritis Res Ther; 2006; 8(1):R13. PubMed ID: 16507114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
    Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.
    Matsushita T; Hasegawa M; Fujimoto M; Hamaguchi Y; Komura K; Hirano T; Horikawa M; Kondo M; Orito H; Kaji K; Saito Y; Matsushita Y; Kawara S; Yasui M; Seishima M; Ozaki S; Kuwana M; Ogawa F; Sato S; Takehara K
    J Rheumatol; 2007 May; 34(5):1012-8. PubMed ID: 17309126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
    Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.